{"id":11642,"date":"2025-11-25T12:23:38","date_gmt":"2025-11-25T12:23:38","guid":{"rendered":"https:\/\/lui.si\/?p=11642"},"modified":"2025-11-25T12:23:38","modified_gmt":"2025-11-25T12:23:38","slug":"eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025","status":"publish","type":"post","link":"https:\/\/lui.si\/en\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/","title":{"rendered":"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge. Dogodek je povezal zdravstvene inovatorje, investitorje, regulatorne strokovnjake in predstavnike industrije ter odprl iskreno razpravo o vplivu regulative, digitalizacije in poslovnih strategij na razvoj sodobnega in trajnostnega zdravstvenega ekosistema.<\/span><\/p>\n<p><b>Potreba po predvidljivih in izvedljivih regulativnih postopkih<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\"> Uvodni gost, Michael Stucky, partner v \u0161vicarskem skladu Serpentine Ventures in izku\u0161en investitor na podro\u010dju deep-techa in biotehnologije, je poudaril, da vlagatelji i\u0161\u010dejo predvidljive poti na trg:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cVse, kar vodi v enostavnej\u0161e, bolj predvidljive in pregledne postopke, je za investitorje bolje. Veliko verjetneje bom investiral, \u010de je pot do trga jasna in predvidljiva.\u201d<\/span><\/i><i><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/i><span style=\"font-weight: 400;\"> Njegova izku\u0161nja, tudi iz ustanovitve in prodaje lastnega biotech podjetja, ka\u017ee, da evropski medtech ekosistem sicer ponuja izjemne prilo\u017enosti, vendar je pogosto prepo\u010dasen in preve\u010d kompleksen.<\/span><\/p>\n<p><b>Regulativa MDR in IVDR \u2013 najve\u010dji izziv malih in srednjih podjetij<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\"> Polona Me\u017ean, direktorica Zbornice ponudnikov medicinske tehnologije in storitev \u2013 MedTech Slovenija (GZS), je predstavila trenutno stanje v panogi:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cUredbi MDR in IVDR sta prinesli velike obremenitve predvsem malim in srednjim podjetjem; nekaj se jih je zaradi tega celo zaprlo \u2013 ne samo v Sloveniji, temve\u010d tudi v Skandinaviji. Glavni izzivi so administrativne obremenitve, pomanjkanje prigla\u0161enih organov, visoki stro\u0161ki skladnosti in tveganje umika izdelkov s trga.\u201d<\/span><\/i><i><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/i><span style=\"font-weight: 400;\"> Dodala je \u0161e:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cZato MedTech Europe pripravlja reformo, ki naj bi podjetjem omogo\u010dila bolj vzdr\u017eno poslovanje. Podjetja lahko pri nas dostopajo do a\u017eurnih informacij prek na\u0161e zbornice, kjer sodelujemo neposredno z MedTech Europe.\u201d<\/span><\/i><i><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/i><span style=\"font-weight: 400;\"> Omenila je tudi nov zakon, ki je za\u010del veljati 19. junija:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cDo 19. decembra morajo biti sprejete nove tarife in pristojbine. Podjetja so preobremenjena, nekateri veliki proizvajalci celo napovedujejo umik proizvodnje iz Slovenije. Na za\u010detku leta 2026 zato pripravljamo novinarsko konferenco.\u201d<\/span><\/i><\/p>\n<p><b>Komercializacija v praksi: alternativni trgi in viri prihodkov<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\"> Dr. Miha \u0160tajdohar, soustanovitelj in tehni\u010dni direktor podjetja Genialis, je mladim podjetjem svetoval:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cVemo, da je zbiranje sredstev te\u017eko, \u0161e posebej brez prihodkov. Zato start-upom svetujem, da razmi\u0161ljajo o alternativnih trgih in alternativnih virih prihodkov.\u201d<\/span><\/i><i><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/i><span style=\"font-weight: 400;\"> Na primeru Genialisa je pojasnil:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cNa\u0161 o\u010diten trg bi bila neposredna prodaja kon\u010dnim uporabnikom, vendar smo namesto tega razvili platformo, ki omogo\u010da hitro gradnjo diagnosti\u010dnih testov. Tako lahko prodajamo farmacevtskim podjetjem za njihove klini\u010dne \u0161tudije, delamo z njihovimi retrospektivnimi podatki ali pa razvijamo teste, ki jih nato licenciramo diagnosti\u010dnim podjetjem \u2013 ta prevzamejo regulativno breme.\u201d<\/span><\/i><i><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/i><span style=\"font-weight: 400;\"> Poudaril je tudi potrebo po razmisleku o neevropskih trgih:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cNe osredoto\u010dajte se samo na EU ali ZDA \u2013 razmislite o Srednjem vzhodu in Aziji, medtem ko \u010dakate na regulativne postopke doma.\u201d<\/span><\/i><\/p>\n<p><b>Zavarovalni\u0161ki postopki \u2013 ovira za uvajanje terapij in izdelkov v Sloveniji<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\"> Polona Me\u017ean je posebno pozornost namenila zavarovalni\u0161kim postopkom:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cTe\u017eko je spraviti terapije na slovenski trg, ker ni dolo\u010denih rokov. Najprej mora zadevo pregledati raz\u0161irjeni strokovni kolegij, nato Zdravstveni svet, nato mora odlo\u010diti zavarovalnica \u2013 in nikjer ni \u010dasovnih okvirjev.\u201d<\/span><\/i><i><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/i><span style=\"font-weight: 400;\"> Poudarila je tudi pomembnost doma\u010dih podjetij:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cV\u010dasih je v Sloveniji prisoten odpor do tega, da bi healthtech podjetja ustvarjala dobi\u010dek. A podjetja zato obstajajo \u2013 in covid \u010dasi, ko ni bilo mask in testov, so pokazali, kako pomembno je imeti lastno proizvodnjo.\u201d<\/span><\/i><\/p>\n<p><b>Priporo\u010dila za start-upe: najprej nedilutivni viri, nato VC<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\"> Moderatorka Charlotte Taft (Pan-Adria Capital) je dala jasen nasvet:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cVedno je dobro najprej preveriti nedilutivne vire financiranja \u2013 evropske razpise in podobne programe \u2013 preden sprejmete VC-investicijo.\u201d<\/span><\/i><i><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/i><span style=\"font-weight: 400;\"> Poudarila je tudi klju\u010dni premislek:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span> <i><span style=\"font-weight: 400;\">\u201cPodjetje mora dolgoro\u010dno ustvarjati prihodke. V Sloveniji je v\u010dasih prisoten predsodek do ustvarjanja dobi\u010dka v zdravstvu, vendar prav podjetja omogo\u010dajo dostop do terapij in medicinskih tehnologij.\u201d<\/span><\/i><\/p>\n<p><b>Odprtost slovenskih bolni\u0161nic za sodelovanje<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\"> V razpravi se je med drugimi oglasila tudi dr. Katja \u0160trancar Fatur iz Splo\u0161ne bolni\u0161nice Izola. Kot odziv na Mihev komentar o te\u017eavah pri iskanju klini\u010dnih partnerjev je izrazila odprtost njihove bolni\u0161nice za sodelovanje pri razvojnih projektih ter \u017eeljo po bolj\u0161em razumevanju postopkov, kako lahko bolni\u0161nice sodelujejo pri razvoju inovacij \u017ee v zgodnjih fazah. S tem se je odprla razprava o povezovanju bolni\u0161nic in start-upov pri testiranju prototipov, validaciji ter razvoju podatkovnih modelov, kar dodatno potrjuje pozitiven vpliv dogodkov, kot je EIT Health Morning Health Talks, na razvoj zdravstvenega ekosistema.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u010ceprav je v zdravstvu dodatni nadzor nujen in so zato postopki pogosto dalj\u0161i ter stro\u017eji kot v drugih panogah, se je na dogodku jasno pokazalo, da lahko pravo\u010dasno vklju\u010devanje bolni\u0161nic, regulatorjev in industrije, skupaj z inovativnimi poslovnimi pristopi in pametnim izkori\u0161\u010danjem nedilutivnih virov financiranja, ob\u010dutno skraj\u0161a pot zdravstvenih inovacij do pacientov. Slovenija ima znanje, voljo in prilo\u017enost, da z bolj\u0161im usklajevanjem teh dele\u017enikov pospe\u0161i razvoj sodobnih zdravstvenih re\u0161itev in okrepi konkuren\u010dnost svojega zdravstvenega ekosistema.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><b>O dogodku<\/b><b><br \/>\n<\/b><span style=\"font-weight: 400;\"> EIT Health Morning Health Talks je serija dogodkov v okviru programa EIT Health RIS, namenjena povezovanju zdravstvenih izvajalcev, predstavnikov zdravstvene industrije, akademskih institucij, odlo\u010devalcev, inovatorjev in investitorjev. Namen dogodkov je spodbujati odprt dialog o izzivih in prilo\u017enostih, ki spremljajo razvoj zdravstvenih inovacij.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\"> V Sloveniji EIT Health Morning Health Talks organizira Ljubljanski univerzitetni inkubator, ki deluje kot EIT Health RIS Representative za Slovenijo.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Za ve\u010d informacij se lahko obrnete na vodjo projekta EIT Health pri Ljubljanskem univerzitetnem inkubatorju: rok.spilar@lui.uni-lj.si<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge.<\/p>","protected":false},"author":4,"featured_media":11645,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[12],"tags":[],"class_list":["post-11642","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-novice"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025 - LUI<\/title>\n<meta name=\"description\" content=\"V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lui.si\/en\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025 - LUI\" \/>\n<meta property=\"og:description\" content=\"V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lui.si\/en\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"LUI\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-25T12:23:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lui\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lui\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/\"},\"author\":{\"name\":\"Lui\",\"@id\":\"https:\/\/lui.si\/#\/schema\/person\/db709e9f4661816cdc63ce5d44831e1e\"},\"headline\":\"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025\",\"datePublished\":\"2025-11-25T12:23:38+00:00\",\"dateModified\":\"2025-11-25T12:23:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/\"},\"wordCount\":921,\"publisher\":{\"@id\":\"https:\/\/lui.si\/#organization\"},\"image\":{\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg\",\"articleSection\":[\"Novice\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/\",\"url\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/\",\"name\":\"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025 - LUI\",\"isPartOf\":{\"@id\":\"https:\/\/lui.si\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg\",\"datePublished\":\"2025-11-25T12:23:38+00:00\",\"dateModified\":\"2025-11-25T12:23:38+00:00\",\"description\":\"V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge.\",\"breadcrumb\":{\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage\",\"url\":\"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg\",\"contentUrl\":\"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lui.si\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lui.si\/#website\",\"url\":\"https:\/\/lui.si\/\",\"name\":\"LUI\",\"description\":\"Ljubljanski univerzitetni inkubator (LUI)\",\"publisher\":{\"@id\":\"https:\/\/lui.si\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lui.si\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lui.si\/#organization\",\"name\":\"LUI\",\"url\":\"https:\/\/lui.si\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lui.si\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lui.si\/wp-content\/uploads\/2024\/08\/LOGO_LUI-1.svg\",\"contentUrl\":\"https:\/\/lui.si\/wp-content\/uploads\/2024\/08\/LOGO_LUI-1.svg\",\"width\":109,\"height\":64,\"caption\":\"LUI\"},\"image\":{\"@id\":\"https:\/\/lui.si\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/lui.si\/#\/schema\/person\/db709e9f4661816cdc63ce5d44831e1e\",\"name\":\"Lui\",\"url\":\"https:\/\/lui.si\/en\/author\/lui_admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025 - LUI","description":"V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lui.si\/en\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/","og_locale":"en_US","og_type":"article","og_title":"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025 - LUI","og_description":"V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge.","og_url":"https:\/\/lui.si\/en\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/","og_site_name":"LUI","article_published_time":"2025-11-25T12:23:38+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg","type":"image\/jpeg"}],"author":"Lui","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lui","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#article","isPartOf":{"@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/"},"author":{"name":"Lui","@id":"https:\/\/lui.si\/#\/schema\/person\/db709e9f4661816cdc63ce5d44831e1e"},"headline":"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025","datePublished":"2025-11-25T12:23:38+00:00","dateModified":"2025-11-25T12:23:38+00:00","mainEntityOfPage":{"@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/"},"wordCount":921,"publisher":{"@id":"https:\/\/lui.si\/#organization"},"image":{"@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg","articleSection":["Novice"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/","url":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/","name":"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025 - LUI","isPartOf":{"@id":"https:\/\/lui.si\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage"},"image":{"@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg","datePublished":"2025-11-25T12:23:38+00:00","dateModified":"2025-11-25T12:23:38+00:00","description":"V Zdravni\u0161ki zbornici Slovenije je v ponedeljek, 24. novembra, potekal drugi leto\u0161nji dogodek EIT Health Morning Health Talks, namenjen osvetlitvi klju\u010dnih izzivov, s katerimi se zdravstveni start-upi soo\u010dajo pri komercializaciji inovacij in vstopu na evropske trge.","breadcrumb":{"@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#primaryimage","url":"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg","contentUrl":"https:\/\/lui.si\/wp-content\/uploads\/2025\/11\/HealthTalks-79-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/lui.si\/novice\/eit-health-morning-health-talks-ozka-grla-pri-komercializaciji-izzivi-zdravstvenih-start-upov-pri-vstopu-na-trge-eu-ljubljana-24-november-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lui.si\/"},{"@type":"ListItem","position":2,"name":"EIT Health Morning Health Talks: Ozka grla pri komercializaciji \u2013 izzivi zdravstvenih start-upov pri vstopu na trge EU Ljubljana, 24. november 2025"}]},{"@type":"WebSite","@id":"https:\/\/lui.si\/#website","url":"https:\/\/lui.si\/","name":"LUI","description":"Ljubljanski univerzitetni inkubator (LUI)","publisher":{"@id":"https:\/\/lui.si\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lui.si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lui.si\/#organization","name":"LUI","url":"https:\/\/lui.si\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lui.si\/#\/schema\/logo\/image\/","url":"https:\/\/lui.si\/wp-content\/uploads\/2024\/08\/LOGO_LUI-1.svg","contentUrl":"https:\/\/lui.si\/wp-content\/uploads\/2024\/08\/LOGO_LUI-1.svg","width":109,"height":64,"caption":"LUI"},"image":{"@id":"https:\/\/lui.si\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lui.si\/#\/schema\/person\/db709e9f4661816cdc63ce5d44831e1e","name":"Lui","url":"https:\/\/lui.si\/en\/author\/lui_admin\/"}]}},"_links":{"self":[{"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/posts\/11642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/comments?post=11642"}],"version-history":[{"count":1,"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/posts\/11642\/revisions"}],"predecessor-version":[{"id":11644,"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/posts\/11642\/revisions\/11644"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/media\/11645"}],"wp:attachment":[{"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/media?parent=11642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/categories?post=11642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lui.si\/en\/wp-json\/wp\/v2\/tags?post=11642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}